Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Researchers at Bristol-Myers Squibb present novel inhibitors of endothelial lipase

Oct. 24, 2013

PDL BioPharma acquires royalty rights and milestones for type 2 diabetes products from Depomed

Oct. 24, 2013

Ferring initiates two phase III trials of infertility treatment candidate FE-999049

Oct. 23, 2013

TherapeuticsMD's TX-12-004-HR estradiol VagiCap shown to improve objective measures of VVA

Oct. 23, 2013

R-Pharm CJSC prepares new fusion proteins that bind to RANKL

Oct. 23, 2013

Eddingpharm to develop Ablynx product ALX-0141 in China

Oct. 22, 2013

Chinese researchers report synthesis of novel DPP IV inhibitors for type 2 diabetes

Oct. 21, 2013

Misodel vaginal delivery system approved for labor induction in Europe

Oct. 18, 2013

Highly selective DPP IV inhibitor shows outstanding results in vivo

Oct. 18, 2013

Yale researchers begin trial of Halozyme's recombinant hyaluronidase in artificial pancreas

Oct. 18, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...